Patricia Cowan
Concepts (236)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Learning | 2 | 2022 | 165 | 1.090 |
Why?
| Students, Nursing | 2 | 2022 | 53 | 1.010 |
Why?
| Faculty, Nursing | 2 | 2022 | 28 | 0.940 |
Why?
| Obesity | 15 | 2015 | 1181 | 0.840 |
Why?
| Kidney Transplantation | 10 | 2015 | 175 | 0.750 |
Why?
| Education, Nursing, Graduate | 2 | 2016 | 21 | 0.730 |
Why?
| Physicians | 1 | 2022 | 236 | 0.710 |
Why?
| Prediabetic State | 2 | 2016 | 23 | 0.710 |
Why?
| Men | 1 | 2015 | 9 | 0.590 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2016 | 457 | 0.540 |
Why?
| Fellowships and Scholarships | 1 | 2015 | 125 | 0.520 |
Why?
| Weight Gain | 5 | 2015 | 232 | 0.450 |
Why?
| Nursing Education Research | 3 | 2022 | 42 | 0.410 |
Why?
| Heart Rate | 7 | 2013 | 369 | 0.370 |
Why?
| Kidney Failure, Chronic | 5 | 2017 | 223 | 0.360 |
Why?
| Education, Professional | 1 | 2008 | 7 | 0.350 |
Why?
| Health Occupations | 1 | 2008 | 12 | 0.350 |
Why?
| Leadership | 2 | 2022 | 120 | 0.340 |
Why?
| African Americans | 5 | 2016 | 717 | 0.330 |
Why?
| Dyslipidemias | 1 | 2007 | 40 | 0.330 |
Why?
| Overweight | 5 | 2013 | 202 | 0.310 |
Why?
| Humans | 44 | 2022 | 53032 | 0.310 |
Why?
| Exercise | 7 | 2013 | 523 | 0.300 |
Why?
| Cardiovascular Diseases | 2 | 2011 | 484 | 0.290 |
Why?
| Blood Glucose | 4 | 2016 | 514 | 0.280 |
Why?
| Internet | 1 | 2008 | 302 | 0.280 |
Why?
| Caregivers | 2 | 2017 | 211 | 0.270 |
Why?
| Insulin Resistance | 3 | 2016 | 324 | 0.270 |
Why?
| Meta-Analysis as Topic | 1 | 2004 | 40 | 0.270 |
Why?
| Sirolimus | 2 | 2003 | 64 | 0.260 |
Why?
| Immunosuppressive Agents | 3 | 2003 | 260 | 0.240 |
Why?
| Insulin | 5 | 2008 | 541 | 0.240 |
Why?
| Evidence-Based Medicine | 1 | 2004 | 309 | 0.230 |
Why?
| Hypertrophy, Left Ventricular | 2 | 2013 | 45 | 0.220 |
Why?
| Body Mass Index | 9 | 2014 | 717 | 0.210 |
Why?
| Male | 28 | 2017 | 28343 | 0.210 |
Why?
| Teaching | 1 | 2022 | 130 | 0.200 |
Why?
| Nurses | 1 | 2020 | 50 | 0.200 |
Why?
| Body Composition | 5 | 2013 | 354 | 0.190 |
Why?
| Graft Rejection | 1 | 2000 | 163 | 0.190 |
Why?
| Hospitals | 1 | 2020 | 163 | 0.190 |
Why?
| Risk Factors | 12 | 2015 | 4007 | 0.190 |
Why?
| Cohort Studies | 4 | 2016 | 1540 | 0.180 |
Why?
| Child | 10 | 2016 | 6933 | 0.180 |
Why?
| Female | 28 | 2016 | 28983 | 0.170 |
Why?
| Islets of Langerhans | 2 | 2008 | 27 | 0.170 |
Why?
| Age Factors | 3 | 2016 | 1267 | 0.160 |
Why?
| Electrocardiography, Ambulatory | 4 | 2013 | 26 | 0.160 |
Why?
| Pancreas Transplantation | 3 | 2003 | 19 | 0.160 |
Why?
| Nurses, Male | 1 | 2016 | 1 | 0.160 |
Why?
| Adolescent | 10 | 2016 | 6886 | 0.160 |
Why?
| Schools, Nursing | 1 | 2016 | 5 | 0.160 |
Why?
| Regression Analysis | 2 | 2016 | 477 | 0.150 |
Why?
| Vulnerable Populations | 1 | 2016 | 42 | 0.150 |
Why?
| Tissue Donors | 2 | 2008 | 106 | 0.150 |
Why?
| Education, Nursing | 1 | 2016 | 27 | 0.150 |
Why?
| Carboxypeptidase H | 1 | 2015 | 1 | 0.150 |
Why?
| Receptors, Dopamine D4 | 1 | 2015 | 9 | 0.150 |
Why?
| Sex Factors | 2 | 2016 | 817 | 0.150 |
Why?
| Multivariate Analysis | 2 | 2016 | 700 | 0.150 |
Why?
| Hypoglycemic Agents | 2 | 2007 | 188 | 0.140 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 49 | 0.140 |
Why?
| Achievement | 1 | 2015 | 46 | 0.140 |
Why?
| Minority Groups | 1 | 2016 | 116 | 0.140 |
Why?
| Adaptation, Psychological | 1 | 2017 | 243 | 0.140 |
Why?
| Qualitative Research | 3 | 2020 | 318 | 0.140 |
Why?
| Career Choice | 1 | 2016 | 121 | 0.140 |
Why?
| Receptors, Dopamine D2 | 1 | 2015 | 18 | 0.140 |
Why?
| Prevalence | 5 | 2011 | 999 | 0.140 |
Why?
| Physical Endurance | 2 | 2005 | 52 | 0.140 |
Why?
| Adult | 20 | 2016 | 14382 | 0.130 |
Why?
| Glucagon | 2 | 2004 | 33 | 0.130 |
Why?
| Protein Precursors | 2 | 2004 | 49 | 0.130 |
Why?
| Octreotide | 2 | 2004 | 17 | 0.130 |
Why?
| Educational Measurement | 1 | 2015 | 234 | 0.120 |
Why?
| Physical Fitness | 1 | 2013 | 71 | 0.120 |
Why?
| United States | 5 | 2020 | 5100 | 0.120 |
Why?
| Child Welfare | 1 | 2013 | 81 | 0.120 |
Why?
| Depressive Disorder | 1 | 2016 | 396 | 0.120 |
Why?
| Electrocardiography | 2 | 2013 | 313 | 0.120 |
Why?
| Blood Pressure | 3 | 2011 | 600 | 0.120 |
Why?
| Clinical Competence | 1 | 2016 | 447 | 0.120 |
Why?
| Glucagon-Like Peptide 1 | 3 | 2008 | 35 | 0.120 |
Why?
| Self Efficacy | 1 | 2013 | 141 | 0.120 |
Why?
| Peptide Fragments | 2 | 2004 | 266 | 0.120 |
Why?
| Sex Offenses | 1 | 2013 | 81 | 0.110 |
Why?
| Motor Activity | 1 | 2013 | 270 | 0.110 |
Why?
| Depression | 1 | 2017 | 606 | 0.110 |
Why?
| Retrospective Studies | 6 | 2016 | 6076 | 0.110 |
Why?
| Long QT Syndrome | 1 | 2011 | 12 | 0.110 |
Why?
| Calcium, Dietary | 1 | 2010 | 18 | 0.100 |
Why?
| Heart Conduction System | 1 | 2010 | 24 | 0.100 |
Why?
| Risk Assessment | 1 | 2016 | 1418 | 0.100 |
Why?
| Cell Separation | 2 | 2008 | 115 | 0.100 |
Why?
| Health Promotion | 1 | 2013 | 303 | 0.100 |
Why?
| Diet | 2 | 2012 | 613 | 0.100 |
Why?
| Child, Preschool | 2 | 2016 | 4144 | 0.090 |
Why?
| Glucose Intolerance | 1 | 2009 | 35 | 0.090 |
Why?
| Insulin-Secreting Cells | 1 | 2008 | 24 | 0.090 |
Why?
| Pilot Projects | 4 | 2015 | 808 | 0.090 |
Why?
| Death, Sudden, Cardiac | 2 | 2000 | 66 | 0.090 |
Why?
| Kidney Diseases | 1 | 2012 | 305 | 0.090 |
Why?
| Liver Transplantation | 2 | 2001 | 154 | 0.090 |
Why?
| Education, Continuing | 1 | 2008 | 22 | 0.090 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2013 | 407 | 0.090 |
Why?
| Energy Intake | 4 | 2015 | 198 | 0.090 |
Why?
| Heart Diseases | 1 | 2011 | 232 | 0.090 |
Why?
| Quality of Life | 3 | 2014 | 821 | 0.080 |
Why?
| Middle Aged | 12 | 2015 | 13685 | 0.080 |
Why?
| Anti-Obesity Agents | 1 | 2007 | 24 | 0.080 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 38 | 0.080 |
Why?
| Islets of Langerhans Transplantation | 1 | 2006 | 2 | 0.080 |
Why?
| Dietary Carbohydrates | 2 | 2004 | 91 | 0.080 |
Why?
| Tissue and Organ Harvesting | 1 | 2006 | 29 | 0.080 |
Why?
| Analysis of Variance | 4 | 2013 | 676 | 0.080 |
Why?
| Metformin | 1 | 2007 | 69 | 0.080 |
Why?
| Veterans | 1 | 2013 | 641 | 0.080 |
Why?
| Young Adult | 5 | 2016 | 4310 | 0.080 |
Why?
| Antihypertensive Agents | 1 | 2007 | 140 | 0.080 |
Why?
| Life Style | 1 | 2007 | 159 | 0.080 |
Why?
| Tennessee | 3 | 2016 | 46 | 0.070 |
Why?
| Attitude to Health | 1 | 2007 | 240 | 0.070 |
Why?
| Pyruvic Acid | 1 | 2005 | 16 | 0.070 |
Why?
| Motivation | 1 | 2007 | 289 | 0.070 |
Why?
| Glucose Tolerance Test | 4 | 2008 | 78 | 0.070 |
Why?
| Glycemic Index | 1 | 2004 | 5 | 0.070 |
Why?
| Primary Health Care | 1 | 2009 | 415 | 0.070 |
Why?
| Aged | 7 | 2015 | 10476 | 0.070 |
Why?
| Bicycling | 1 | 2004 | 45 | 0.070 |
Why?
| Task Performance and Analysis | 1 | 2004 | 70 | 0.070 |
Why?
| Statistics as Topic | 1 | 2004 | 108 | 0.060 |
Why?
| Exercise Test | 2 | 2005 | 153 | 0.060 |
Why?
| Anthropometry | 3 | 2013 | 99 | 0.060 |
Why?
| Mycophenolic Acid | 1 | 2003 | 18 | 0.060 |
Why?
| Inflammation | 1 | 2008 | 671 | 0.060 |
Why?
| Calcium | 1 | 2005 | 468 | 0.060 |
Why?
| Eating | 1 | 2003 | 157 | 0.060 |
Why?
| Renal Dialysis | 2 | 2000 | 182 | 0.060 |
Why?
| Patient Selection | 2 | 2000 | 300 | 0.060 |
Why?
| Transplantation Immunology | 1 | 2000 | 7 | 0.050 |
Why?
| Dietary Supplements | 1 | 2005 | 451 | 0.050 |
Why?
| Workflow | 1 | 2020 | 53 | 0.050 |
Why?
| Autonomic Nervous System Diseases | 1 | 2000 | 12 | 0.050 |
Why?
| Drug Costs | 1 | 2000 | 40 | 0.050 |
Why?
| Intestinal Absorption | 1 | 2000 | 68 | 0.050 |
Why?
| Weight Loss | 1 | 2003 | 267 | 0.050 |
Why?
| Prospective Studies | 5 | 2009 | 2452 | 0.050 |
Why?
| Safety | 1 | 2000 | 103 | 0.050 |
Why?
| Nurse's Role | 1 | 2000 | 98 | 0.050 |
Why?
| Drug Interactions | 1 | 2000 | 220 | 0.050 |
Why?
| Renal Insufficiency | 1 | 2001 | 135 | 0.050 |
Why?
| Patient Safety | 1 | 2020 | 128 | 0.050 |
Why?
| Arrhythmias, Cardiac | 1 | 2000 | 103 | 0.050 |
Why?
| Reference Values | 2 | 2013 | 390 | 0.050 |
Why?
| Feeding Behavior | 2 | 2014 | 200 | 0.040 |
Why?
| Clinical Trials as Topic | 1 | 2000 | 502 | 0.040 |
Why?
| Case-Control Studies | 3 | 2013 | 1268 | 0.040 |
Why?
| Thermolysin | 2 | 2008 | 3 | 0.040 |
Why?
| Collagenases | 2 | 2008 | 29 | 0.040 |
Why?
| Postoperative Complications | 2 | 2003 | 1080 | 0.040 |
Why?
| Cost of Illness | 1 | 2017 | 134 | 0.040 |
Why?
| School Admission Criteria | 1 | 2016 | 37 | 0.040 |
Why?
| Linear Models | 2 | 2007 | 322 | 0.040 |
Why?
| Minisatellite Repeats | 1 | 2015 | 9 | 0.040 |
Why?
| Educational Status | 1 | 2016 | 223 | 0.040 |
Why?
| Optogenetics | 1 | 2015 | 8 | 0.040 |
Why?
| Time Factors | 4 | 2005 | 3439 | 0.030 |
Why?
| Program Development | 1 | 2016 | 226 | 0.030 |
Why?
| Cell Survival | 2 | 2008 | 695 | 0.030 |
Why?
| Logistic Models | 2 | 2009 | 1032 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2015 | 147 | 0.030 |
Why?
| Sensitivity and Specificity | 2 | 2013 | 973 | 0.030 |
Why?
| Treatment Outcome | 2 | 2007 | 5645 | 0.030 |
Why?
| Neuroimaging | 1 | 2015 | 99 | 0.030 |
Why?
| Social Support | 1 | 2016 | 303 | 0.030 |
Why?
| Reward | 1 | 2015 | 121 | 0.030 |
Why?
| Physical Education and Training | 1 | 2013 | 28 | 0.030 |
Why?
| School Health Services | 1 | 2013 | 49 | 0.030 |
Why?
| Curriculum | 1 | 2016 | 415 | 0.030 |
Why?
| Double-Blind Method | 2 | 2005 | 759 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2015 | 570 | 0.030 |
Why?
| Body Weight | 1 | 2015 | 603 | 0.030 |
Why?
| ROC Curve | 1 | 2013 | 256 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2015 | 583 | 0.030 |
Why?
| Program Evaluation | 1 | 2013 | 414 | 0.030 |
Why?
| Diet Records | 1 | 2010 | 25 | 0.030 |
Why?
| Neurons | 1 | 2015 | 484 | 0.030 |
Why?
| Minerals | 1 | 2010 | 32 | 0.030 |
Why?
| Vitamins | 1 | 2010 | 53 | 0.030 |
Why?
| Echocardiography | 1 | 2013 | 386 | 0.020 |
Why?
| Cholesterol | 1 | 2009 | 139 | 0.020 |
Why?
| Physical Examination | 1 | 2009 | 102 | 0.020 |
Why?
| Diabetes Complications | 2 | 2000 | 124 | 0.020 |
Why?
| C-Peptide | 1 | 2008 | 25 | 0.020 |
Why?
| Cadaver | 1 | 2008 | 121 | 0.020 |
Why?
| Nursing Evaluation Research | 1 | 2007 | 48 | 0.020 |
Why?
| Diet, Reducing | 1 | 2007 | 44 | 0.020 |
Why?
| Adiposity | 1 | 2008 | 144 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2008 | 162 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2006 | 100 | 0.020 |
Why?
| Comorbidity | 1 | 2009 | 700 | 0.020 |
Why?
| Mice, SCID | 1 | 2006 | 201 | 0.020 |
Why?
| Mice | 2 | 2008 | 6403 | 0.020 |
Why?
| Follow-Up Studies | 2 | 2003 | 2452 | 0.020 |
Why?
| Health Services Needs and Demand | 1 | 2007 | 200 | 0.020 |
Why?
| Mass Screening | 1 | 2009 | 385 | 0.020 |
Why?
| Behavior Therapy | 1 | 2007 | 202 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2007 | 713 | 0.020 |
Why?
| Gels | 1 | 2004 | 20 | 0.020 |
Why?
| Honey | 1 | 2004 | 8 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2013 | 3642 | 0.020 |
Why?
| Lipids | 1 | 2005 | 170 | 0.020 |
Why?
| Gastrointestinal Agents | 1 | 2004 | 37 | 0.020 |
Why?
| Cross-Over Studies | 1 | 2004 | 266 | 0.020 |
Why?
| Oxygen Consumption | 1 | 2005 | 240 | 0.020 |
Why?
| Fasting | 1 | 2003 | 74 | 0.020 |
Why?
| Prednisone | 1 | 2003 | 117 | 0.010 |
Why?
| Hormones | 1 | 2003 | 66 | 0.010 |
Why?
| Hypertension | 1 | 2008 | 558 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2007 | 1582 | 0.010 |
Why?
| Glucose | 1 | 2004 | 352 | 0.010 |
Why?
| Animals | 2 | 2008 | 14806 | 0.010 |
Why?
| Sickness Impact Profile | 1 | 2000 | 38 | 0.010 |
Why?
| Adipose Tissue | 1 | 2003 | 245 | 0.010 |
Why?
| Cyclosporine | 1 | 2001 | 71 | 0.010 |
Why?
| Tacrolimus | 1 | 2001 | 50 | 0.010 |
Why?
| Living Donors | 1 | 2000 | 21 | 0.010 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2000 | 103 | 0.010 |
Why?
| Hospitals, University | 1 | 2000 | 96 | 0.010 |
Why?
| Research | 1 | 2000 | 118 | 0.010 |
Why?
| Graft Survival | 1 | 2000 | 169 | 0.010 |
Why?
| Circadian Rhythm | 1 | 1999 | 92 | 0.010 |
Why?
| Disease Progression | 1 | 2001 | 900 | 0.010 |
Why?
| Risk | 1 | 1998 | 361 | 0.010 |
Why?
| Survival Rate | 1 | 2000 | 1016 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 1998 | 1067 | 0.010 |
Why?
|
|
Cowan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
|